You just read:

Keryx Biopharmaceuticals Announces Oral Presentation of Final Zerenex™ Short-Term Phase 3 Data at the Upcoming National Kidney Foundation's 2011 Spring Clinical Meetings

News provided by

Keryx Biopharmaceuticals, Inc.

Mar 07, 2011, 08:30 EST